NCT03515980View on ClinicalTrials.gov

An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

May 25, 2018

Primary Completion Date

August 29, 2019

Study Completion Date

August 29, 2019

Conditions
Liver DysfunctionLiver InsufficiencyHepatic FailureMyocardial FailureCardiac FailureCongestive Heart FailureHeart Decompensation
Interventions
DRUG

BMS-986231

Intravenous (IV) administration

Trial Locations (4)

1083

Semmelweis Egyetem Altalanos Orvostudomanyi Kar, Budapest

3529

Clinical Research Unit Hungary, Miskolc

05-410

BioVirtus Centrum Medyczne, Józefów

20-954

KO-MED Centra Kliniczne Lublin, Lublin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY